Truncated L1 protein of Human Papillomavirus type 16
AssigneesBeijing Wantai Biological Pharmacy Enterprise Co., Ltd., Xiamen University
InventorsYing Gu, Shaowei Li, Minxi Wei, Yangling Xian, Wenxin Luo, Ningshao Xia
Life of this patent
Estimating the term…
Abstract
The invention relates to a truncated L1 protein of the Human Papillomavirus Type 16, a virus-like particle consisting of the protein, a vaccine comprising said virus-like particle, and the use of the vaccine in the prevention of cervical cancer.
Claims17
A truncated recombinant human papilloma virus type 16 (HPV 16) L1 protein that is truncated at its N-terminus, wherein the protein consists of the amino acid sequence of SEQ ID NO:6 or 7.
A recombinant polynucleotide encoding a HPV16 L1 protein that is truncated at its N-terminus, wherein the protein consists of the amino acid sequence of SEQ ID NO:6 or 7.
Dependencies are inferred from the claim text.